Clinicians should not give pregnant women magnesium sulfate for more than five to seven days due to reports claiming reduced calcium levels and bone abnormalities in babies, the FDA warned on Thursday. Off-label uses of the drug include the prevention of preterm labor as well as seizures during pregnancy, but officials said the labeling would be changed to emphasize that the medication is not indicated for preventing preterm labor.

Full Story:

Related Summaries